首站-论文投稿智能助手
典型文献
National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China(English version)
文献摘要:
Contents 1.Introduction 2.Diagnostic techniques and applications 2.1 Risk factors for pancreatic cancer 2.2 Clinical manifestations 2.3 Physical examination 2.4 Radiological examination 2.4.1 Ultrasound 2.4.2 Computed tomography(CT) 2.4.3 Magnetic resonance imaging(MRI)and magnetic resonance cholangiopancreatography(MRCP) 2.4.4 Positron emission tomography-CT(PET-CT) 2.4.5 Endoscopic ultrasonography(EUS) 2.4.6 Role of ERCP in diagnosis of pancreatic cancer 2.4.7 Bone scans 2.5 Blood immunologic and biochemical examinations 2.5.1 Blood biochemical examination 2.5.2 Serum tumor markers 2.6 Histologic and cytological diagnosis 2.6.1 Cytological pathology diagnosis 2.6.2 Histopathology diagnosis of pancreatic cancer 2.6.3 Immunohistochemistry 2.6.4 Pathologic reports of pancreatic cancer 2.7 Differential diagnosis of pancreatic cancer 2.7.1 Chronic pancreatitis 2.7.2 Carcinoma of ampulla 2.7.3 Pancreatic cystadenoma and cystadenocarcinoma 2.7.4 Choledocholithiasis 2.7.5 Other lesions of pancreas 3.Classification and staging of pancreatic cancer 3.1 Histologic classification of pancreatic cancer 3.2 Staging of pancreatic cancer(AJCC,the 8th edition) 3.2.1 Definition ofT,N and M in pancreatic TNM staging 3.2.2 TNM staging for pancreatic cancer
文献关键词:
作者姓名:
National Health Commission of the People's Republic of China
作者机构:
引用格式:
[1]National Health Commission of the People's Republic of China-.National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China(English version))[J].中国癌症研究(英文版),2022(03):238-255
A类:
Histologic,Histopathology,cystadenoma,cystadenocarcinoma,Choledocholithiasis,ofT
B类:
National,guidelines,diagnosis,treatment,pancreatic,cancer,China,English,version,Contents, 1,Introduction, 2,Diagnostic,techniques,applications,Risk,factors,Clinical,manifestations,Physical,Radiological,Ultrasound,Computed,tomography,Magnetic,resonance,imaging,magnetic,cholangiopancreatography,MRCP,Positron,emission,PET,Endoscopic,ultrasonography,EUS,Role,ERCP,Bone,scans,Blood,immunologic,biochemical,examinations,Serum,tumor,markers,cytological,Cytological,Immunohistochemistry,Pathologic,reports,Differential,Chronic,pancreatitis,Carcinoma,ampulla,Pancreatic,Other,lesions,pancreas, 3,Classification,staging,classification,Staging,AJCC,8th,edition,Definition,TNM
AB值:
0.502152
相似文献
Value of contrast-enhanced ultrasound combined with percutaneous ultrasound-guided fine-needle aspiration in the diagnosis of solid pancreatic lesions
Gui Yang;Dai Menghua;Meng Zhilan;Chang Xiaoyan;Tan Li;Zhang Jing;Chen Xueqi;Zhou Tongtong;Zhang Qing;Xiao Mengsu;Lyu Ke;Jiang Yuxin-Department of Ultrasound, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China;Department of Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China;Department of Pathology, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
Hepatopancreatoduodenectomy for advanced biliary malignancies
Wu Xiangsong;Li Maolan;Wu Wenguang;Wang Xu’an;Li Huaifeng;Bao Runfa;Shu Yijun;Shen Jun;Gu Jun;Wang Xuefeng;Gong Wei;Peng Shuyou;Liu Yingbin-Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai 200092, China;Shanghai Research Center of Biliary Tract Disease, Shanghai 200092, China;Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;State Key Laboratory of Oncogenes and Related Genes, Shanghai 200092, China;Department of General Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejing 310009, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。